The Texas Heart Institute Provides BiVACOR® Total Artificial Heart Patient Update
Successful first-in-human bridge to heart transplant with revolutionary valveless artificial heart Houston, Texas, July 26, 2024 – The Texas Heart...
Alexis Shafii
The Texas Heart Institute Makes a Strong Showing at ISHLT 2023
Daniel Timms, PhD, founder and chief technical officer of BiVACOR, Inc., described the benchtop testing and preclinical studies performed with...
Sharing Our Latest Research With the World
Our Professional Staff members have demonstrated a commitment to advancing cardiovascular science. This can be seen in their research output....
How the Texas Medical Center’s Extracorporeal Membrane Oxygenation Specialists Teamed Up to Save Lives During the COVID Crisis
From the early stages of the COVID-19 pandemic, critical care medicine professionals on clinical teams across the Texas Medical Center...
Preoperative Hyponatremia Predicts Poorer Long-Term Survival in Patients Receiving LVADs
With the constant goal of improving treatment for patients with heart failure, clinical investigators at Texas Heart Institute and Baylor...
